Search Results - "Del Nero, A"

Refine Results
  1. 1
  2. 2

    COLLAGEN FOR U.I. MINIMAL DOSE INJECTIONS IN SCHEDULED STEPS TO IMPROVE CLINICAL RESULTS by Mantovani, F., Del Nero, A., Confalonieri, S., Pisani, E.

    Published in Urogynaecologia international journal (01-07-2010)
    “…Endoscopic treatment of urinary incontinence is based on the use of injectables. We use collagen (Contigen-Bard) to make the bladder neck narrower in order to…”
    Get full text
    Journal Article
  3. 3

    Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: comparison with urinary cytology and BTA test by Del Nero, A, Esposito, N, Currò, A, Biasoni, D, Montanari, E, Mangiarotti, B, Trinchieri, A, Zanetti, G, Serrago, M P, Pisani, E

    Published in European urology (01-02-1999)
    “…In the present study we compared the clinical value of two new specific tests for transitional cell carcinoma, urinary nuclear matrix protein (NMP22) levels…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Renal stone fragments following shock wave lithotripsy by Zanetti, G, Seveso, M, Montanari, E, Guarneri, A, Del Nero, A, Nespoli, R, Trinchieri, A

    Published in The Journal of urology (01-08-1997)
    “…We describe a select group of asymptomatic patients with fragments and dust 3 months after extracorporeal treatment, who were followed to evaluate the…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    An assessment of the main metabolic variables of cardiovascular risk in a sample population of workers in Rome by Gueli, N, Del Nero, A, Zia, N, Carmenini, E, Cacciafesta, M

    Published in Panminerva medica (01-12-2001)
    “…The last few years have seen an increased necessity to assess the cardiovascular risk factors on large samples of the population in Italy. A look at the…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Life habits and cardiovascular risk in a group of bank employees in Rome by Gueli, N, del Nero, A, Zia, N, Carmenini, E, Carmenini, G

    Published in Panminerva medica (01-06-2000)
    “…For the past thirty years, many countries, especially the USA, have been performing clinical and laboratory studies to establish the most prominent disease…”
    Get more information
    Journal Article
  17. 17

    Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump by Damascelli, B, Marchianò, A, Spreafico, C, Lutman, R, Salvetti, M, Bonalumi, M G, Mauri, M, Garbagnati, F, Del Nero, A, Comeri, G

    Published in Cancer (15-07-1990)
    “…The authors treated 42 metastatic renal cell carcinoma (RCC) patients who had received no previous chemotherapy or radiation therapy with circadian venous…”
    Get more information
    Journal Article
  18. 18

    Ultrasound-fluoroscopy guided access to the intrarenal excretory system by Montanari, E, Serrago, M, Esposito, N, Rocco, B, Kartalas-Goumas, I, Del Nero, A, Zanetti, G, Trinchieri, A, Pisani, E

    Published in Annales d'urologie (1999)
    “…The access to the collecting system can be performed under fluoroscopy computerized tomography, ultrasonographic, mixed ultrasonographic and fluoroscopic…”
    Get more information
    Journal Article
  19. 19

    Contact laser treatment for benign prostatic hypertrophy by Montanari, E, Guarneri, A, Pozzoni, F, Gelosa, M, Del Nero, A, Trinchieri, A, Zanetti, G, Pisani, E

    Published in Archivio italiano di urologia, andrologia (01-06-1999)
    “…Transurethral resection of the prostate (TURP) is still the standard treatment of benign prostatic hypertrophy (BPH) but the surgical lasers recently…”
    Get more information
    Journal Article
  20. 20

    Prognostic significance of prostate-specific antigen in endocrine treatment for prostatic carcinoma by Zanetti, G, Trinchieri, A, Del Nero, A, Montanari, E, Cogni, M, Colombo, F, Buzzetti, V, Austoni, E

    Published in European urology (1992)
    “…We have studied the prognostic significance of prostate-specific antigen (PSA), monitored monthly, in 24 patients with prostatic cancer (5 D1, 19 D2) on…”
    Get more information
    Journal Article